StockData
Apnimed, Inc. logo

Apnimed, Inc. (APMD) stock

APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.80+1.52 (+9.34%)

Close on Nov 17, 2026Market cap $85.47MP/E –Yield –

Apnimed r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.90M–
Q2 FY2025Jun 30, 2025$15.97M–

More Apnimed figures

See a number that looks wrong?